Patent 12298313

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-flash

PTAB activity (2)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

1 active
  • IPR2026-00270IPRfiled Feb 26, 2026vs. Sarepta Therapeutics, Inc. et al.Pending
  • IPR2026-00166IPRfiled Dec 2, 2025vs. Sarepta Therapeutics, Inc. et al.Terminated

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (1)

Group view →

Specific litigation cases in our database that name US patent 12298313. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

Known litigation involving US patent 12298313 includes the following:

  1. PTAB Case IPR2026-00270

    • Plaintiff(s): Sarepta Therapeutics, Inc.
    • Defendant(s): Genzyme Corp.
    • Jurisdiction: U.S. Patent and Trademark Office (PTAB)
    • Case Number: IPR2026-00270
    • Filing Date: Not explicitly provided in the search results, but filed prior to May 18, 2026.
    • Outcome or Current Status: Awaiting an institution decision (as of May 18, 2026).

  2. PTAB Case IPR2026-00166

    • Plaintiff(s): Sarepta Therapeutics Inc.
    • Defendant(s): Genzyme Corp.
    • Jurisdiction: U.S. Patent and Trademark Office (PTAB)
    • Case Number: IPR2026-00166
    • Filing Date: December 2, 2025
    • Outcome or Current Status: Procedural Termination (terminated on March 25, 2026).

Generated 5/29/2026, 6:49:04 AM